Compare Barrick Gold Corp (B) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Barrick Gold Corp vs Sana Biotechnology Inc — how do they compare? Barrick Gold Corp trades at $41.2 (market cap $65.92B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: Barrick Gold Corp is far larger — about 58.3× Sana Biotechnology Inc's market cap, and Barrick Gold Corp pays a 1.74% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| B | SANA | |
|---|---|---|
Market Cap | $65.92B | $1.13B |
Sector | Basic Materials | Health |
52-Week High | $52.97 | $5.92 |
52-Week Low | $23.50 | $2.68 |
Enterprise Value | $64.67B | $1.05B |
Dividend Yield | 1.74% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Barrick Mining (B) trades at $40.91, down 6.36% today, but maintains strong fundamentals with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $40 and resistance at $42, while recent developments include a $1.95 billion settlement with Newmont and plans for a North American gold IPO. Revenue growth accelerated to $17.0 billion in 2025 with net income reaching $5.0 billion, supported by a 31.6% net margin.
The outlook remains positive with 66.7% analyst buy ratings and a $49.83 consensus price target representing 22% upside. Key risks include gold price volatility and execution of the planned IPO, but strong cash flow generation and debt reduction provide stability for continued shareholder returns through dividends and potential buybacks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Barrick Gold Corp
Barrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.
Read more on B →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
